Metabolic effects of L-carnitine, L-lysine methionin during maximal exercise;EFFETS METABOLIQUES DE L'ASSOCIATION L-CARNITINE - L-LYSINE - METHIONINE CONTRE PLACEBO AU COURS D'EXERCICES SUBMAXIMAUX

Science and Sports

Volumn 13, Issue 1, 1998, Pages 17-25

  Reynier, M ^a   Brun, J F ^a   Orsetti, A ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Carnitine; Exercise; Insulin sensitivity; Minimal model

Indexed keywords

ACYL COENZYME A; CARBOHYDRATE; CARNITINE; LYSINE; METHIONINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; KINETICS; LACTATE BLOOD LEVEL; MALE; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031886238     PISSN: 07651597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0765-1597(97)82988-7     Document Type: Article

References (27)

1. 1 Anonyme. Carnitine deficiency. Lancet 1990;335:631-32
2. 2 Bergman RN. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 1989;38:1512-27
3. 3 Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exercise 1982;14:377-81
4. 4 Brun JF, Fédou C, Monnier JF, Jourdan N, Orsetti A. Relationships between insulin resistance measured with the minimal model and microalbuminuria in type 2 (non-insulin dependent) diabetics. Endocrinol Metab 1995;2:203-3
5. 5 Brun JF, Guintrand-Hugret R, Boegner C, Bouix O, Orsetti A. Influence of short submaximal exercise on paramelers of glucose assimilation analyzed with the minimal model. Metabolism 1995;44 833-40
6. 6 Brun JF, Monnier JF, Jourdan N, Orsetti A. Correction de l'insulino-résistance sans changement de l'efficience glucidique après exercice submaximal bref chez des DNIDs [Abstract]. Diabetes Metab 1995;21:
7. 7 Brun JF, Bouix O, Monnier JF et al. Increased insulin sensitivity and basal insulin effectiveness in postprandial reactive hypoglycaemia. Acta Diabetol 1996; 33:1-6
8. 8 Capaldo B, Napoli R, DiBonito P, Albano G, Saccà L. Carnitine improves peripheral glucose disposal in non-insulin dependent diabetic patients. Diabetes Res Clin Pract 1991;14:191-6
9. 9 Cederblad G, Blund AC, Holm J, Scherten T. Carnitine concentration in relation to enzymes activities and substrate utilization in human skeletal muscles. Scand J Clin Lab Invest 1976;36:547-52
10. 10 Engel A. Carnitine deficiency syndrome and lipid storage myopathies. In: Engel A, Anker B, eds. Myology, basic and clinical. New York: Mc Graw Hill Book Co, 1986:1663-96
11. 11 Ferrannini E, Buzzigoli G, Bevilacqua Boni C et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 1988;255:E946-52 (Endocrinol Metab 1988;18:E946-52)
12. 12 Fritz IB. Action of Carnitine on long-chain fatty acid oxidation by liver. Am J Physiol 1959;197:297-304
13. 13 Guézennec CY. Faut-il donner de la carnitine aux sportifs. Cah Nutr Diet 1994;29:172-7
14. 14 Gulewitsch WI, Krimberg R. Zur kenninis der extraktivstoffe der muskelnn. II Mitteilung uber das carnitin. Hoppe Seyler's Z Physiol Chem 1905;45:326-30
15. 15 Harichaux P, Jullien H, Libert JP. Activité physique et carnitine : le mythe et la réalité. Méd Sport 1994;68:197-207
16. 16 Jenkins AB, Furler SM, Bruce DG, Chisholm DJ. Regulation of hepatic glucose output during moderate exercise in non-insulin dependent diabetes. Metabolism 1988;37:966-72
17. 17 Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ. Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab 1995;80:364-9
18. 18 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
19. 19 Mitchell ME. Carnitine metabolismin human subjects. Am J Clin Nutr 1978;31:293-306
20. 20 Mitchell ME. Carnitine metabolism in human subjects. II. Values of carnitine in biological fluids and tissues of normal subjects. Am J Clin Nutr 1978;31:481-91
21. 21 Moceilin R, Lindemann H, Rutenfranz J, Sbresny W. Determination of W170 and maximal oxygen uptake in children by different methods. Acta Paediat Scand 1971;217(suppl):13-7
22. 22 Pierrefiche G, Reynier M, Laborit H. Carnitine action on neuromuscular disturbances in the fasting rat: potentiation by L-lysine. Pharmacology 1993;46:33-42
23. 23 Prentki M, Corkey BE. Are the β-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 1996;45:273-83
24. 24 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607
25. 25 Reynier M. Contribution à l'étude théorique et expérimentale des propriétés biologiques de la carnitine. Agressologie 1963;4:361-72
26. 26 Scheen AJ, Lethiexhe MR, Lefèbvre PJ. Effects of metformin in obese patients with impaired glucose tolerance. Diabetes Metab Revs 1995;11:S69-S80
27. 27 Wahlund H. Determination of physical working capacity. Acta Med Scand 1948;215:1-78